Operator
Greetings, and welcome to the Avadel Pharmaceuticals Fourth Quarter and Full-Year 2020 Earnings Call. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions]
I will now turn the conference over to your host, Tom McHugh. You may begin.
Thomas S. McHugh
Chief Financial Officer
Good morning, and thank you for joining us on our conference call. This morning, we issued our full year and fourth quarter financial results news release. The release can be accessed on our website, www.avadel.com.
As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. These risks include risks that products in the